Invasive lobular vs. ductal breast cancer: A stage-matched comparison of outcomes

Annals of Surgical Oncology

Volumn 17, Issue 7, 2010, Pages 1862-1869

  Wasif, Nabil ^a,d   Maggard, Melinda A ^b   Ko, Clifford Y ^b,c   Giuliano, Armando E ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; BREAST CONSERVATION SURGERY; BREAST SURGERY; CANCER SIZE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; LOBULAR BREAST CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; PROGNOSIS; TREATMENT OUTCOME; AGED; BREAST NEOPLASMS; CANCER REGISTRY; CANCER STAGING; CARCINOMA, DUCTAL, BREAST; CLINICAL TRIAL; COMPARATIVE STUDY; LUNG CARCINOMA; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; SURVIVAL RATE; TUMOR INVASION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; SEER PROGRAM; SURVIVAL RATE;

EID: 77954955272     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-0953-z     Document Type: Article

References (34)

1. Fisher ER, Gregorio RM, Fisher B, et al. The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4). Cancer. 1975;36:1-85.
2. Li CI, Anderson BO, Porter P, et al. Changing incidence rate of invasive lobular breast carcinoma among older women. Cancer. 2000;88:2561-9.
3. Martinez V, Azzopardi JG. Invasive lobular carcinoma of the breast: incidence and variants. Histopathology. 1979;3:467-88.
4. De Leeuw WJ, Berx G, Vos CB, et al. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol. 1997;183:404-11.
5. Cleton-Jansen AM. E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer? Breast Cancer Res. 2002;4:5-8.
6. Le Gal M, Ollivier L, Asselain B, et al. Mammographic features of 455 invasive lobular carcinomas. Radiology. 1992;185:705-8.
7. Krecke KN, Gisvold JJ. Invasive lobular carcinoma of the breast: mammographic findings and extent of disease at diagnosis in 184 patients. AJR Am J Roentgenol. 1993;161:957-60.
8. Arpino G, Bardou VJ, Clark GM, et al. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res. 2004;6: R149-56.
9. Cristofanilli M, Gonzalez-Angulo A, Sneige N, et al. Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes. J Clin Oncol. 2005;23:41-8.
10. Molland JG, Donnellan M, Janu NC, et al. Infiltrating lobular carcinoma-a comparison of diagnosis, management and outcome with infiltrating duct carcinoma. Breast. 2004;13:389-96.
11. Pestalozzi BC, Zahrieh D, Mallon E, et al. Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials. J Clin Oncol. 2008;26:3006-14.
12. Sastre-Garau X, Jouve M, Asselain B, et al. Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer. 1996;77:113-20.
13. Silverstein MJ, Lewinsky BS, Waisman JR, et al. Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer. 1994;73:1673-7.
14. Allemani C, Sant M, Berrino F, et al. Prognostic value of morphology and hormone receptor status in breast cancer-a population-based study. Br J Cancer. 2004;91:1263-8.
15. Li CI, Moe RE, Daling JR. Risk of mortality by histologic type of breast cancer among women aged 50 to 79 years. Arch Intern Med. 2003;163:2149-53.
16. Toikkanen S, Pylkkanen L, Joensuu H. Invasive lobular carcinoma of the breast has better short-and long-term survival than invasive ductal carcinoma. Br J Cancer. 1997;76:1234-40.
17. du Toit RS, Locker AP, Ellis IO, et al. An evaluation of differences in prognosis, recurrence patterns and receptor status between invasive lobular and other invasive carcinomas of the breast. Eur J Surg Oncol. 1991;17:251-7.
18. Mhuircheartaigh JN, Curran C, Hennessy E, et al. Prospective matched-pair comparison of outcome after treatment for lobular and ductal breast carcinoma. Br J Surg. 2008;95:827-33.
19. Viale G, Rotmensz N, Maisonneuve P, et al. Lack of prognostic significance of "classic" lobular breast carcinoma: a matched, single institution series. Breast Cancer Res Treat. 2009;117:211-4.
20. Jayasinghe UW, Bilous AM, Boyages J. Is survival from infiltrating lobular carcinoma of the breast different from that of infiltrating ductal carcinoma? Breast J. 2007;13:479-85.
21. Korhonen T, Huhtala H, Holli K. A comparison of the biological and clinical features of invasive lobular and ductal carcinomas of the breast. Breast Cancer Res Treat. 2004;85:23-9.
22. Mersin H, Yildirim E, Gulben K, et al. Is invasive lobular carcinoma different from invasive ductal carcinoma? Eur J Surg Oncol. 2003;29:390-5.
23. Ashikari R, Huvos AG, Urban JA, et al. Infiltrating lobular carcinoma of the breast. Cancer. 1973;31:110-6.
24. Mate TP, Carter D, Fischer DB, et al. A clinical and histopathologic analysis of the results of conservation surgery and radiation therapy in stage I and II breast carcinoma. Cancer. 1986;58:1995-2002.
25. Havener L. Standards for cancer registries volume III: standards for completeness, quality, analysis, and management of data. North American Association of Central Cancer Registries 2004.
26. Surveillance, Epidemiology, and End Results (SEER) Program. Public Use Data (1973-2005). National Cancer Institute. http://www.seer.cancer.gov. Accessed November 2008.
27. Greene FL, Page DL, Fleming ID. AJCC Cancer Staging Manual, 6th ed. Springer, New York; 2002.
28. Rakha EA, El-Sayed ME, Powe DG, et al. Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes. Eur J Cancer. 2008;44:73-83.
29. Tubiana-Hulin M, Stevens D, Lasry S, et al. Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution. Ann Oncol. 2006;17:1228-33.
30. Katz A, Saad ED, Porter P, et al. Primary systemic chemotherapy of invasive lobular carcinoma of the breast. Lancet Oncol. 2007;8:55-62.
31. Wickerham DL, O'Connell MJ, Costantino JP, et al. The half century of clinical trials of the National Surgical Adjuvant Breast And Bowel Project. Semin Oncol. 2008;35:522-9.
32. Bouvet M, Ollila DW, Hunt KK, et al. Role of conservation therapy for invasive lobular carcinoma of the breast. Ann Surg Oncol. 1997;4:650-4.
33. Santiago RJ, Harris EE, Qin L, et al. Similar long-term results of breast-conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: The University of Pennsylvania experience. Cancer. 2005;103:2447-54.
34. Singletary SE, Patel-Parekh L, Bland KI. Treatment trends in early-stage invasive lobular carcinoma: a report from the National Cancer Data Base. Ann Surg. 2005;242:281-9.